Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Uropathogenic Escherichia coli ST131 in urinary tract infections in children

  • Yun, Ki Wook (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Lee, Mi-Kyung (Department of Laboratory Medicine, Chung-Ang University College of Medicine) ;
  • Kim, Wonyong (Department of Microbiology, Chung-Ang University College of Medicine) ;
  • Lim, In Seok (Department of Pediatrics, Chung-Ang University College of Medicine)
  • Received : 2017.01.26
  • Accepted : 2017.04.11
  • Published : 2017.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Escherichia coli sequence type (ST) 131, a multidrug-resistant clone causing extraintestinal infections, has rapidly become prevalent worldwide. However, the epidemiological and clinical features of pediatric infections are poorly understood. We aimed to explore the characteristics of ST131 Escherichia coli isolated from Korean children with urinary tract infections. Methods: We examined 114 uropathogenic E. coli (UPEC) isolates from children hospitalized at Chung-Ang University Hospital between 2011 and 2014. Bacterial strains were classified into STs by partial sequencing of seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and recA). Clinical characteristics and antimicrobial susceptibility were compared between ST131 and non-ST131 UPEC isolates. Results: Sixteen UPEC isolates (14.0%) were extended-spectrum ${\beta}-lactamase$ (ESBL)-producers; 50.0% of ESBL-producers were ST131 isolates. Of all the isolates tested, 13.2% (15 of 114) were classified as ST131. There were no statistically significant associations between ST131 and age, sex, or clinical characteristics, including fever, white blood cell counts in urine and serum, C-reactive protein, radiologic abnormalities, and clinical outcome. However, ST131 isolates showed significantly lower rates of susceptibility to cefazolin (26.7%), cefotaxime (40.0%), cefepime (40.0%), and ciprofloxacin (53.3%) than non-ST131 isolates (65.7%, 91.9%, 92.9%, and 87.9%, respectively; P<0.001 for all). ESBL was more frequently produced in ST131 (53.3%) than in non-ST131 (8.1%) isolates (P<0.01). Conclusion: ST131 E. coli isolates were prevalent uropathogens in children at a single medical center in Korea between 2011 and 2014. Although ST131 isolates showed higher rates of antimicrobial resistance, clinical presentation and outcomes of patients were similar to those of patients infected with non-ST131 isolates.

Keywords

References

  1. Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med 2011;365:239-50. https://doi.org/10.1056/NEJMra1007755
  2. Lee HS, Lee KH. Clinical characteristics of fever without localizing sign in infants younger than 100 days of age in a single center. Pediatr Infect Vaccine 2016;23:128-36. https://doi.org/10.14776/piv.2016.23.2.128
  3. Ahn DH, Kim KW, Cho HK, Tchah H, Jeon IS, Ryoo E, et al. Febrile urinary tract infections caused by community-acquired extendedspectrum beta-lactamase-producing and-nonproducing bacteria: a comparative study. Pediatr Infect Vaccine 2015;22:29-35. https://doi.org/10.14776/piv.2015.22.1.29
  4. Kocak M, Buyukkaragoz B, Celebi Tayfur A, Caltik A, Koksoy AY, Cizmeci Z, et al. Causative pathogens and antibiotic resistance in children hospitalized for urinary tract infection. Pediatr Int 2016;58:467-71. https://doi.org/10.1111/ped.12842
  5. Smith SP, Manges AR, Riley LW. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Clin Infect Dis 2008;46:689-95. https://doi.org/10.1086/527386
  6. Cheng MF, Chen WL, Hung WY, Huang IF, Chiou YH, Chen YS, et al. Emergence of extended spectrum-${\beta}$-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants. Pediatr Infect Dis J 2015;34:469-75. https://doi.org/10.1097/INF.0000000000000623
  7. Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 2013;57:1256-65. https://doi.org/10.1093/cid/cit503
  8. Can F, Azap OK, Seref C, Ispir P, Arslan H, Ergonul O. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections. Clin Infect Dis 2015;60:523-7. https://doi.org/10.1093/cid/ciu864
  9. Cho SY, Kang CI, Cha MK, Wi YM, Ha YE, Chung DR, et al. Clinical features and treatment outcomes of bloodstream infections caused by extended-spectrum ${\beta}$-Lactamase-producing escherichia coli sequence type 131. Microb Drug Resist 2015;21:463-9. https://doi.org/10.1089/mdr.2014.0261
  10. Yun KW, Kim DS, Kim W, Lim IS. Molecular typing of uropathogenic Escherichia coli isolated from Korean children with urinary tract infection. Korean J Pediatr 2015;58:20-7. https://doi.org/10.3345/kjp.2015.58.1.20
  11. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004;186:1518-30. https://doi.org/10.1128/JB.186.5.1518-1530.2004
  12. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8. https://doi.org/10.1128/AEM.66.10.4555-4558.2000
  13. Kim JM, Cho EY, Lee JH. Phylogenetic groups and virulence factors of Escherichia coli causing urinary tract infection in children. Pediatr Infect Vaccine 2015;22:194-200. https://doi.org/10.14776/piv.2015.22.3.194
  14. Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol 2005;43:5860-4. https://doi.org/10.1128/JCM.43.12.5860-5864.2005
  15. Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9:466-75. https://doi.org/10.1016/j.mib.2006.08.011
  16. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011;66:1-14. https://doi.org/10.1093/jac/dkq415
  17. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010;51:286-94. https://doi.org/10.1086/653932
  18. Tiruvury H, Johnson JR, Mariano N, Grenner L, Colon-Urban R, Erritouni M, et al. Identification of CTX-M ${\beta}$-lactamases among Escherichia coli from the community in New York City. Diagn Microbiol Infect Dis 2012;72:248-52. https://doi.org/10.1016/j.diagmicrobio.2011.11.008
  19. Gqunta K, Govender S. Characterization of ESBL-producing Escherichia coli ST131 isolates from Port Elizabeth. Diagn Microbiol Infect Dis 2015;81:44-6. https://doi.org/10.1016/j.diagmicrobio.2014.10.006
  20. Park SH, Byun JH, Choi SM, Lee DG, Kim SH, Kwon JC, et al. Molecular epidemiology of extended-spectrum ${\beta}$-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 2012; 12:149. https://doi.org/10.1186/1471-2334-12-149
  21. Kang CI, Cha MK, Kim SH, Ko KS, Wi YM, Chung DR, et al. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum beta-lactamase-producing escherichia coli over a 6-year period. J Korean Med Sci 2013;28:998-1004. https://doi.org/10.3346/jkms.2013.28.7.998
  22. Lee JE, Lee YH, Nam CH, Kwak GY, Lee SY, Kim JH, et al. Clinical and phylogenetic characteristics of escherichia coli urinary tract infections. Korean J Pediatr Infect Dis 2010;17:16-22. https://doi.org/10.14776/kjpid.2010.17.1.16
  23. Choi UY, Han SB, Lee SY, Kang JH, Kim SM, Ma SH. Regional differences in phylogenetic group of Escherichia coli strains isolated from children with urinary tract infection in Korea. Korean J Pediatr 2012;55:420-3. https://doi.org/10.3345/kjp.2012.55.11.420
  24. Lukac PJ, Bonomo RA, Logan LK. Extended-spectrum ${\beta}$-lactamaseproducing Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis 2015;60:1389-97.
  25. Kizilca O, Siraneci R, Yilmaz A, Hatipoglu N, Ozturk E, Kiyak A, et al. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int 2012; 54:858-62. https://doi.org/10.1111/j.1442-200X.2012.03709.x
  26. Lee B, Kang SY, Kang HM, Yang NR, Kang HG, Ha IS, et al. Outcome of antimicrobial therapy of pediatric urinary tract infections caused by extended-spectrum ${\beta}$-lactamase-producing enterobacteriaceae. Infect Chemother 2013;45:415-21. https://doi.org/10.3947/ic.2013.45.4.415

Cited by

  1. Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages vol.32, pp.3, 2017, https://doi.org/10.1128/cmr.00135-18
  2. Molecular Epidemiology of Antimicrobial Resistance of Uropathogenic Escherichia coli Isolates from Patients with Urinary Tract Infections in a Tertiary Teaching Hospital in Iran vol.26, pp.1, 2020, https://doi.org/10.1089/mdr.2019.0184
  3. Emergence of Escherichia coli ST131 Causing Urinary Tract Infection in Western Asia: A Systematic Review and Meta-Analysis vol.26, pp.11, 2020, https://doi.org/10.1089/mdr.2019.0312
  4. Extended-spectrum β-lactamase-producing Escherichia coli isolated from raw vegetables in South Korea vol.10, pp.1, 2020, https://doi.org/10.1038/s41598-020-76890-w
  5. Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated from Vegetable Farm Soil in South Korea vol.27, pp.11, 2017, https://doi.org/10.1089/mdr.2020.0542